Patrick leads the multidisciplinary Technology Group at Taylor Vinters.
A nationally recognised leading IP lawyer specialising in looking after technology businesses’ commercial needs, he loves getting IP deals done. He has developed a detailed knowledge of the interface between the public and private sector and works extensively with high growth entrepreneurial businesses.
Throughout his career, Patrick has specialised in IP matters and technology (in particular patents and know-how), with a particular focus on the life sciences sector. He also has experience in advising on:
- IP licences
- R&D agreements
- Joint ventures
- Spin-outs and start-ups
- Competition law aspects of commercial contracts
- Regulatory issues
- Strategic partnerships
Patrick has recently advised Discuva on its transformational deal with Roche, involving a $16 million upfront and research fees, and payments on multiple programmes of up to $175 million per product. He recently advised on IP aspects of the recent Cambridge University spin-outs XO1, MorphogenIX, Storm Therapeutics, 8Power and Roadmap.
Patrick read law at the University of London. He qualified as a solicitor in 1989 and joined Taylor Vinters in 2005, moving his team from a major national law firm.
Things you might not know – he is a dual UK and Swiss national and fluent French speaker. He is also a regular indie gig goer (although sadly rarely now seen in the mosh pit), and dreams of having a sense of rhythm so his children might let him turn up the volume on his bass guitar amp.
Patrick is regularly endorsed as leading IP lawyer in Legal 500, Chambers and PLC’s Which Lawyer (Life Sciences) Guide. He is also a Chair of the University of Cambridge’s Technology Appeals Tribunal.